BGM
BGM Group Ltd. Class A Ordinary SharesBGM
BGM
About: BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
Employees: 323
0
Funds holding %
of 7,372 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
965% more capital invested
Capital invested by funds: $3.59K [Q3] → $38.2K (+$34.6K) [Q4]
50% more funds holding
Funds holding: 2 [Q3] → 3 (+1) [Q4]
0.05% more ownership
Funds ownership: 0.01% [Q3] → 0.06% (+0.05%) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for BGM.
Financial journalist opinion
Neutral
PRNewsWire
1 week ago
BGM Group Announces Board Reshuffle: New Leadership Embarks on a Transformative Journey Amid Tech Revolution
CHENGDU, China , Feb. 28, 2025 /PRNewswire/ -- BGM Group Ltd (NASDAQ: BGM) (the "Company" or "BGM") today announced changes to its board of directors, marking the Company's entry into a new phase of technological transformation and sustainable growth. Mr. Zhanchang Xin has tendered his resignation and will step down from his role as Chairman of the Company, effective March 1, 2025.
Neutral
PRNewsWire
3 weeks ago
BGM Group Establishes "Duxiaobao Management Committee" to Accelerate AI Strategy and Drive Intelligent Transformation in the Insurance Industry
CHENGDU, China , Feb. 19, 2025 /PRNewswire/ -- BGM Group Ltd. (Nasdaq: BGM) announced the establishment of the "Duxiaobao Management Committee," which will be fully responsible for the management and decision-making of the "Duxiaobao" ecosystem.
Neutral
PRNewsWire
2 months ago
BMG Completed Acquisition of High-Quality Assets, Marking a New Chapter in Diversified Growth
CHENGDU, China , Dec. 27, 2024 /PRNewswire/ -- BGM Group Ltd. (Nasdaq: BGM) (the "Company" or "BGM"), a leading global pharmaceutical enterprise, today announced completion of the acquisition of the intelligent platform of AIX Inc. It marks BGM's official entry into the domains of AI intelligent technology and financial/insurance services, opening up new opportunities for the integrated development of healthcare, pharmaceuticals, and insurance on a global scale.
Neutral
PRNewsWire
2 months ago
In-Depth Analysis of BGM Group: Innovating Pharmaceuticals and Insurance through AI
CHONGQING, China , Dec. 27, 2024 /PRNewswire/ -- BGM Group Ltd. (Stock Code: BGM) has successfully acquired Rongshu Technology and Xinbao Investment Company, both subsidiaries of AIX Corp. (Stock Code: AIFU), in a transaction valued at approximately $140 million.
Neutral
PRNewsWire
2 months ago
BGM Group and Jointown Deepen Cooperation, Ushering in a New Era of Pharmaceutical Development
CHENGDU, China , Dec. 19, 2024 /PRNewswire/ -- BGM Group Ltd. (NASDAQ: BGM) ("the Company" or "BGM"), Mr.
Neutral
PRNewsWire
3 months ago
AIX Inc. (NASDAQ:AIFU): Reshaping AI Insurance and the Healthcare Industry--A Promising Future Ahead?
HONG KONG , Nov. 29, 2024 /PRNewswire/ -- AIX Inc. (NASDAQ:AIFU) is a leading company focused on insurance agency and claims services. Recently, the company has been gradually pushing for an intelligent and diversified transformation, aiming to capture growth opportunities in the AI insurance and healthcare sectors.
Charts implemented using Lightweight Charts™